Quality of Life Among Heroin Users on Buprenorphine versus Methadone Maintenance
The American Journal of Drug and Alcohol AbusePublished 1 January 2007
Alexander M. Ponizovsky, Alexander Grinshpoon
Citations115
SJR quartileQ2
SJR score0.89
SNIP0.78
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The results show the beneficial effects of the maintenance treatment programs using both buprenorphine and methadone with regard to satisfaction with QoL and all specific life domains among heroin-dependent outpatients, with methamphetamineadone having an earlier onset than bupenorphine.
Abstract
The results show the beneficial effects of the maintenance treatment programs using both buprenorphine and methadone with regard to satisfaction with QoL and all specific life domains among heroin-dependent outpatients, with methadone having an earlier onset than buprenorphine. Further studies are needed to identify the factors linked to these benefits and their time course.
Keywords
Medicine
Cochrane Database of Systematic ReviewsBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
2,250 Citations2014Richard P. Mattick, Courtney Breen +2 more
Buprenorphine maintenance compared to placebo and to methadone maintenance in the management of opioid dependence, including its ability to retain people in treatment, suppress illicit drug use, reduce criminal activity, and mortality is evaluated.
PubMedQuality of Life Enjoyment and Satisfaction Questionnaire: a new measure.
1,915 Citations1993Jane Endicott, J. Nee +2 more
The findings suggest that the Q-LES-Q measures may be sensitive to important differences among depressed patients that are not detected by the measures usually employed.
American Journal of PsychiatryQuality-of-Life Impairment in Depressive and Anxiety Disorders
902 Citations2005Mark Hyman Rapaport, Cathryn M. Clary +2 more
Subjects with affective or anxiety disorders who enter clinical trials have significant quality-of-life impairment, although the degree of dysfunction varies, and diagnostic-specific symptom measures explained only a small proportion of the variance in quality of life.
Journal of Substance Abuse TreatmentAn overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research
564 Citations2005Laura Amato, Marina Davoli +4 more
These findings confirm that MMT at appropriate doses is the most effective in retaining patients in treatment and suppressing heroin use but show weak evidence of effectiveness toward other relevant outcomes.
The Journal of Clinical PsychiatryDifferences in Quality of Life Domains and Psychopathologic and Psychosocial Factors in Psychiatric Patients
223 Citations2000Michael S. Ritsner, Ilan Modai +6 more
A distress protection model to enhance life satisfaction for severe mental disorder patients is proposed on the basis of the results of factor analysis and better understanding of the combining effects of psychopathology and psychosocial factors on subjective life satisfaction.
Journal of Palliative MedicineMethadone Use in Cancer Patients with Pain: A Review
198 Citations2002Éduardo Bruera, Catherine Sweeney
Future research should address the use of methadone as a first-line agent in the management of cancer pain, its use in patients with neuropathic pain, and in those who develop rapid tolerance to other opioids.
The American Journal of Drug and Alcohol AbuseQuality of Life Assessments by Adult Substance Abusers Receiving Publicly Funded Treatment in Massachusetts
187 Citations2003Kevin W. Smith, Mary Jo Larson
The results of this study suggest that the physical functioning of adult substance abusers is similar to the levels for patients diagnosed with other serious chronic diseases, but that mental functioning is much lower.
AddictionA meta‐analysis comparing buprenorphine to methadone for treatment of opiate dependence
151 Citations2001Paul G. Barnett, John H. Rodgers +1 more
The difference in the effectiveness of buprenorphine and methadone may be statistically significant, but the differences are small compared to the wide variance in outcomes achieved in different methadon treatment programs.
PsychopharmacologyEffects of buprenorphine and methadone in methadone-maintained subjects
124 Citations1995Sharon Walsh, Harry L. June +4 more
It is suggested that abrupt transition from methadone to buprenorphine may produce patient discomfort that is positively related to both methad one maintenance dose and bupenorphine transition dose.
Psychological MedicineA mediational model of quality of life for individuals with severe mental health problems
113 Citations1998Anastasia Zissi, Margaret M. Barry +1 more
The results indicate that perceived improvements in lifestyle, greater autonomy and positive self-concept are significantly and directly associated with better quality of life and may have important implications for the planning and delivery of mental health programmes.
The Journal of Nervous and Mental DiseasePrognostic Factors in Buprenorphine- versus Methadone-Maintained Patients
90 Citations1998Richard S. Schottenfeld, Juliana Pakes +1 more
Lifetime sedative dependence was associated with significantly better retention, decreased rates of cocaine-positive urine samples, and increased rate of cocaine abstinence; among buprenorphine- but not methadone-maintained patients, it was also associated with increased rates of abstinence from illicit opioids.
Expert Opinion on PharmacotherapyCombating opiate dependence: a comparison among the available pharmacological options
75 Citations2004Gerardo González, Alison Oliveto +1 more
The two major goals of pharmacotherapy are to relieve the severity of opiate withdrawal symptoms during the managed withdrawal of the opioid and to prevent relapse to heroin use either after abstinence initiation or after being stabilised on a long-acting opiate agonist, such as methadone.
The Scientific World JOURNALSublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment
73 Citations2005Salvatore Giacomuzzi, M. Ertl +3 more
The present data indicate that buprenorphine is also a useful long-term alternative for maintenance treatment of opioid-dependent patients and that opioid addicts improved their QOL and health status when treated with methadone or bupenorphine.
Contemporary Family TherapyBehavioral and neurochemical commonalities in addiction
65 Citations1991S. G. Sunderwirth, Harvey B. Milkman
A unified model of addiction is applied which relates behavioral similarities to manifestations of altered neurochemistry in that portion of the limbic system responsible for reward to individuals involved in compulsive activities.
American Journal on AddictionsImplementing Buprenorphine Treatment in Community Settings in Australia: Experiences from the Buprenorphine Implementation Trial
59 Citations2004Nicholas Lintzeris, Alison Ritter +4 more
An overview of key developments in the introduction of buprenorphine treatment in Australia is provided, with an emphasis upon the delivery of services in community-based (primary care) settings.
Drug and Alcohol DependenceComparison of intravenously administered methadone, morphine and heroin
52 Citations1986Donald R. Jasinski, Kenzie L. Preston
Under the conditions of the experiment methadone produced a profile of effects which was indistinguishable from that of morphine and heroin, and its relative potencies were constant over all opiate-like effects, including measures of euphoria.
PubMedNeurobiology of addictive behaviors and its relationship to methadone maintenance.
49 Citations2000Barry Stimmel, Mary Jeanne Kreek
There is ample evidence now that disruption of several components of the endogenous opioid system, ranging from changes in gene expression to changes in behavior, may occur during cycles of short-acting opiate abuse.
Expert Opinion on PharmacotherapyOpioid maintenance: a comparative review of pharmacological strategies
46 Citations2006Jason M. White, Olga V. Lopatko
This review examines the existing strategies, highlights problems associated with their use and discusses the opportunities for new treatment approaches, particularly the use of long-acting formulations.
Journal of Pharmacology and Experimental TherapeuticsComparison of Intravenous Buprenorphine and Methadone Self-Administration by Recently Detoxified Heroin-Dependent Individuals
44 Citations2005Sandra D. Comer, Maria A. Sullivan +1 more
It is demonstrated that under these experimental conditions, buprenorphine and methadone were equally effective in producing reinforcing and subjective effects.
Substance Use & MisuseOpioid Addicts at Admission vs. Slow-Release Oral Morphine, Methadone, and Sublingual Buprenorphine Maintenance Treatment Participants
42 Citations2006Salvatore Giacomuzzi, Georg Kemmler +2 more
It is suggested that slow-release oral morphine could have some disadvantages compared with sublingual buprenorphine and methadone in QOL, physical symptoms, and additional consumption, and more research is required.
Addictive BehaviorsWell-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine
21 Citations2006Alexander M. Ponizovsky, Alexander Grinshpoon +3 more
Compared with patients treated with clonidine, patients who received buprenorphine developed significantly less side-effects and related distress, and had higher senses of well-being, self-efficacy and social support.
PubMedMethadone and buprenorphine maintenance therapies for patients with hepatitis C virus infected after intravenous drug use.
21 Citations2005Rita Verrando, Geert Robaeys +2 more
A substitution treatment program effectively reduces and often eliminates heroin injection behaviour, rendering patients more socially stabilised, and it may be necessary to increase the dosage of methadone during interferon treatment.
International Journal of the AddictionsMethadone Maintenance Treatment: The Other Side of the Coin
19 Citations1983David P. Ausubel
The psychopharmacological rationale and clinical effectiveness of the methadone maintenance treatment program was subjected to critical theoretical and methodological analysis and it was concluded that the MMTP constitutes and perpetuates an immature coping mechanism.